- ►annals.org PH Masur, JE Kaplan, KK Holmes - Annals of internal medicine, 2002 - Am Coll Physicians Summary: In 1995, the US Public Health Service (USPHS) and the Infectious Diseases Society
of America (IDSA) developed guidelines for preventing opportunistic infections (OIs) among persons
infected with human immunodeficiency virus (HIV); these guidelines were updated in ... Cited by 346 - Related articles - BL Direct - All 9 versions
- ►annals.org [PDF] O Kirk, P Reiss, C Uberti-Foppa, M Bickel, J … - Annals of internal …, 2002 - Am Coll Physicians Patients: 358 patients taking potent antiretroviral therapy (>3 drugs) who interrupted maintenance
therapy at a CD4 lymphocyte count greater than 50 106 cells/L. Measurements: Recurrence
of opportunistic infection after in- terruption of maintenance therapy. Results: 379 ... Cited by 77 - Related articles - BL Direct - All 6 versions
A Registered, P Login, P Options, SD Access - The Lancet, 1999 - thelancet.com The rate of discontinuation of primary and secondary PCP prophylaxis increased up to 21—9
discontinuations per 100 person-years of follow-up after March, 1998. 378 patients discontinued
primary (319) or secondary (59) prophylaxis a median of 10 months after starting HAART. ... Cited by 195 - Related articles - Cached - BL Direct - All 4 versions
- ►ucl.ac.uk [PDF] B Ledergerber, A Mocroft, P Reiss, H Furrer, O … - New England Journal …, 2001 - content.nejm.org Results Secondary prophylaxis was discontinued at a median CD4 cell count of 350 per cubic
millimeter; the median nadir CD4 cell count had been 50 per cubic millimeter. The median duration
of the increase in the CD4 cell count to more than 200 per cubic millimeter after ... Cited by 155 - Related articles - BL Direct - All 11 versions
RF Breiman, DW Keller, MA Phelan, DH … - Archives of Internal …, 2000 - archinte.highwire.org Methods Case patients were 18- to 55-year-old subjects with HIV infection who were admitted
to selected hospitals in Atlanta or San Francisco from February 1992 to April 1995 from whom
Streptococcus pneumoniae was isolated from a normally sterile site. Controls were HIV- ... Cited by 139 - Related articles - BL Direct - All 4 versions
A Vibhagool, S Sungkanuparph, P … - Clinical Infectious …, 2003 - UChicago Press Featured in Toronto Star "Pigs, viruses and politics" May 2, 2009 Are Swine Workers in the United
States at Increased Risk of Infection with Zoonotic Influenza Virus? Kendall P. Myers, Christopher
W. Olsen, Sharon F. Setterquist, Ana W. Capuano, Kelley J. Donham, Eileen L. Thacker, ... Cited by 74 - Related articles - BL Direct - All 7 versions
DV Havlir, MP Dube, FR Sattler, DN Forthal, … - New England Journal …, 1996 - content.nejm.org Results In an intention-to-treat analysis, the incidence of disseminated M. avium complex infection
at one year was 15.3 percent with rifabutin, 7.6 percent with azithromycin, and 2.8 percent with
both drugs. The risk of the infection in the azithromycin group was half that in the rifabutin ... Cited by 241 - Related articles - BL Direct - All 7 versions
KA Gebo, RD Moore, JC Keruly, RE Chaisson - The Journal of infectious …, 1996 - jstor.org Page 1. 857 Risk Factors for Pneumococcal Disease in Human Immunodeficiency Virus- Infected
Patients Kelly A. Gebo, Richard D. Moore, Jeanne C. Keruly, and Richard E. Chaisson Department
of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland ... Cited by 98 - Related articles - BL Direct - All 4 versions
N French, J Nakiyingi, LM Carpenter, E Lugada, C … - The Lancet, 2000 - Elsevier First invasive events occurred in 25 individuals (24 bacteraemias, one pyomyositis), 15 in the
vaccine arm and ten in the placebo arm (hazard ratio [HR] 1·47; 95% CI 0·7–3·3). 22 isolates
(88%) were of vaccine-specific serogroups with 15 events in the vaccine arm compared ... Cited by 258 - Related articles - BL Direct - All 10 versions
WM El-Sadr, WJ Burman, LB Grant, JP Matts, … - The New England …, 2000 - ncbi.nlm.nih.gov BACKGROUND: Several agents are effective in preventing Mycobacterium avium complex disease
in patients with advanced human immunodeficiency virus (HIV) infection. However, there is uncertainty
about whether prophylaxis should be continued in patients whose CD4+ cell counts have ... Cited by 90 - Related articles
